IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

Children with bronchopulmonary dysplasia belong to the risk group of severe respiratory-syncytial viral infection (RSV). World experience and authors' own clinical data show that seasonal immunoprophylaxis of RSV infection's severe course by palivizumab in these patients allows reducing frequency of...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	A. A. Baranov, I. V. Davydova, T. V. Turti, L. S. Namazova-Baranova, V. V. Altunin, E. P. Zimina, E. V. Pavlyukova
Formaat:	Artigo
Taal:	Russo
Gepubliceerd in:	Union of pediatricians of Russia 2012-12-01
Reeks:	Педиатрическая фармакология
Onderwerpen:	respiratory-syncytial virus bronchopulmonary dysplasia acute respiratory viral infection respiratory function palivizumab
Online toegang:	https://www.pedpharma.ru/jour/article/view/268
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!